Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 21, 2010

View Archived Issues

FDA approves folate-containing oral contraceptive Safyral

UCB claims new PI3K inhibitors

ClanoTech divulges new inhibitors of VEGFR-2 and VEGFR-3

Panobinostat/capecitabine/lapatinib combination is safe in HER2+ breast cancer

Clinical and preclinical data presented on GDC-0941/T-DM1 in HER2+ breast cancer

NS-018 preferentially targets V617F-mutant JAK2

MRx-102 shows promise in models of AML

Enrollment complete in phase IIb COMPONENT trial of vidofludimus in RA

EMA's CHMP recommends approval of Esbriet for IPF

Janssen submits European MAA for telaprevir in chronic hepatitis C

FDA grants fast track status for elacytarabine in AML

Lpath enters into an option license agreement with Pfizer for iSONEP

EMA provides update on safety review for somatropin-containing medicines

Bristol-Myers Squibb and Oncolys sign licensing agreement for festinavir

Manhattan Pharma reports preliminary phase I/II data on AST-915

Scientists identify new susceptibility loci for Hodgkin's lymphoma

GSK and Impax collaborate on late-stage Parkinson's disease therapeutic

New selective JAK1 inhibitors disclosed by Incyte

Idera Pharma reports phase I data on IMO-2125 in hepatitis C

Willfact to be launched in additional European countries

Bayer and Regeneron report topline phase III data on VEGF Trap-Eye

Gilead Sciences acquires Arresto Biosciences

New inhibitors CK II and/or pim-1 discovered at Cylene Pharma

New inhibitors of Aurora kinase A and B presented

Tasigna approved in Japan for newly diagnosed Ph+ CML

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...